Biological and clinical factors associated with peripheral neuropathy in rheumatoid arthritis cohort

This retro-prospective cross-sectional study investigated the relationship between biological and clinical factors and peripheral neuropathy within a population of patients with rheumatoid arthritis. The sample size consisted of 63 individuals enrolled in the study. Researchers compared patients with rheumatoid arthritis who had peripheral neuropathy against a comparator group of patients with rheumatoid arthritis without peripheral neuropathy.

The primary outcome focused on the presence of peripheral neuropathy. The intervention or exposure involved assessing biological and clinical factors, specifically rheumatoid factor, C-reactive protein, and anti-citrullinated peptide antibodies. No medications were reported as part of the intervention or exposure assessment.

The provided data does not contain specific main results or numerical values regarding the association between the assessed factors and the outcome. Consequently, no specific percentages, p-values, or effect sizes can be quoted from the input. The significance threshold was set at a p-value, but the actual threshold value is not reported.

Safety data regarding adverse events, serious adverse events, discontinuations, and tolerability were not reported in the source material. Key limitations include the study design and the unspecified significance threshold. The evidence is observational, preventing causal inferences about the biological factors.

Practice relevance is limited due to the lack of reported quantitative outcomes. Clinicians should recognize that this study provides preliminary observational data without definitive statistical conclusions. Further research with reported numerical results is necessary to establish clinical utility.